Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback